Symbols / EVH Stock $3.07 -1.13% Evolent Health, Inc.
EVH (Stock) Chart
About
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Stock Fundamentals
Scroll to Statements| Market Cap | 342.17M | Enterprise Value | 1.18B | Income | -579.40M | Sales | 1.88B | Book/sh | 3.72 | Cash/sh | 1.36 |
| Dividend Yield | — | Payout | 0.00% | Employees | 4200 | IPO | — | P/E | — | Forward P/E | 6.94 |
| PEG | 1.93 | P/S | 0.18 | P/B | 0.82 | P/C | — | EV/EBITDA | 13.42 | EV/Sales | 0.63 |
| Quick Ratio | 1.20 | Current Ratio | 1.31 | Debt/Eq | 238.37 | LT Debt/Eq | — | EPS (ttm) | -5.07 | EPS next Y | 0.44 |
| EPS Growth | — | Revenue Growth | -27.50% | Earnings | 2026-05-07 | ROA | -0.12% | ROE | -66.54% | ROIC | — |
| Gross Margin | 21.31% | Oper. Margin | -2.06% | Profit Margin | -28.49% | Shs Outstand | 111.64M | Shs Float | 92.79M | Short Float | 14.47% |
| Short Ratio | 5.14 | Short Interest | — | 52W High | 12.06 | 52W Low | 2.10 | Beta | 0.37 | Avg Volume | 3.20M |
| Volume | 317.58K | Target Price | $5.18 | Recom | Strong_buy | Prev Close | $3.10 | Price | $3.06 | Change | -1.13% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-02 | main | Oppenheimer | Outperform → Outperform | $6 |
| 2026-02-26 | main | Citigroup | Buy → Buy | $4 |
| 2026-02-26 | main | UBS | Buy → Buy | $5 |
| 2026-02-26 | main | Truist Securities | Buy → Buy | $6 |
| 2026-02-25 | main | Needham | Buy → Buy | $4 |
| 2026-02-25 | main | RBC Capital | Sector Perform → Sector Perform | $3 |
| 2026-02-25 | down | Keybanc | Overweight → Sector Weight | — |
| 2026-02-25 | main | BTIG | Buy → Buy | $8 |
| 2026-02-02 | main | BTIG | Buy → Buy | $10 |
| 2026-01-09 | main | Citigroup | Buy → Buy | $6 |
| 2026-01-06 | main | Citizens | Market Outperform → Market Outperform | $10 |
| 2025-11-21 | main | Citigroup | Buy → Buy | $10 |
| 2025-11-17 | main | JP Morgan | Overweight → Overweight | $7 |
| 2025-11-14 | main | Canaccord Genuity | Buy → Buy | $9 |
| 2025-11-13 | init | BMO Capital | — → Outperform | $7 |
| 2025-11-12 | main | Oppenheimer | Outperform → Outperform | $12 |
| 2025-11-10 | main | Truist Securities | Buy → Buy | $10 |
| 2025-11-10 | main | Citizens | Market Outperform → Market Outperform | $11 |
| 2025-11-07 | main | BTIG | Buy → Buy | $16 |
| 2025-09-30 | reit | BTIG | Buy → Buy | $20 |
News
RSS: Latest EVH news- Is Evolent Health (EVH) stock forming a breakout today (Risk Aversion) 2026-04-22 - Real-time Trade Ideas - UBND thành phố Hải Phòng hu, 23 Apr 2026 02
- Evolent Health (EVH) Stock Chart | Q4 2025: Profit Surprises - Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 19
- $EVH stock is up 23% today. Here's what we see in our data. - Quiver Quantitative ue, 21 Apr 2026 14
- EVH Stock Grinds Higher As Traders Watch Momentum - StocksToTrade ue, 21 Apr 2026 18
- Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results - PR Newswire ue, 24 Feb 2026 08
- Evolent Health (EVH) Shares Skyrocket, What You Need To Know - Yahoo Finance Wed, 25 Feb 2026 08
- Evolent schedules May 7 results release, 8 a.m. ET investor call - Stock Titan ue, 07 Apr 2026 07
- Why Evolent Health (EVH) Shares Are Sliding Today - Yahoo Finance Wed, 19 Nov 2025 08
- EVH (Evolent Health Inc) beats Q4 2025 EPS forecasts, but shares drop five percent amid mixed investor sentiment. - Margin Improvement - UBND thành phố Hải Phòng hu, 23 Apr 2026 10
- Evolent Health (EVH) Stock Trades Up, Here Is Why - Yahoo Finance Wed, 24 Sep 2025 07
- EVOLENT HEALTH ($EVH) Releases Q4 2025 Earnings - Quiver Quantitative ue, 24 Feb 2026 08
- 3 Reasons to Sell EVH and 1 Stock to Buy Instead - Yahoo Finance Mon, 17 Nov 2025 08
- $EVH stock is up 14% today. Here's what we see in our data. - Quiver Quantitative Fri, 21 Nov 2025 08
- Why Evolent Health (EVH) Shares Are Sliding Today - Yahoo Finance Wed, 12 Nov 2025 08
- Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance ue, 07 Apr 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,876.23
-26.56%
|
2,554.74
+30.09%
|
1,963.90
+45.26%
|
1,352.01
|
| Operating Revenue |
|
1,876.23
-26.56%
|
2,554.74
+30.09%
|
1,963.90
+45.26%
|
1,352.01
|
| Cost Of Revenue |
|
1,476.35
-32.51%
|
2,187.39
+45.49%
|
1,503.43
+45.20%
|
1,035.43
|
| Reconciled Cost Of Revenue |
|
1,476.35
-32.51%
|
2,187.39
+45.49%
|
1,503.43
+45.20%
|
1,035.43
|
| Gross Profit |
|
399.88
+8.86%
|
367.35
-20.22%
|
460.47
+45.45%
|
316.58
|
| Operating Expense |
|
419.72
+10.04%
|
381.42
-20.79%
|
481.52
+43.11%
|
336.46
|
| Selling General And Administration |
|
303.87
+15.52%
|
263.05
-26.54%
|
358.11
+32.99%
|
269.27
|
| General And Administrative Expense |
|
—
|
—
|
—
|
—
|
| Other Gand A |
|
—
|
—
|
—
|
—
|
| Total Expenses |
|
1,896.06
-26.19%
|
2,568.81
+29.41%
|
1,984.95
+44.69%
|
1,371.89
|
| Operating Income |
|
-19.83
-41.00%
|
-14.07
+33.19%
|
-21.05
-5.91%
|
-19.88
|
| Total Operating Income As Reported |
|
-410.14
-913.06%
|
-40.48
+43.15%
|
-71.21
-2055.27%
|
3.64
|
| EBITDA |
|
-361.31
-551.33%
|
80.06
+423.00%
|
-24.79
-219.79%
|
20.69
|
| Normalized EBITDA |
|
85.02
-20.15%
|
106.47
+129.56%
|
46.38
+530.18%
|
7.36
|
| Reconciled Depreciation |
|
115.85
-2.13%
|
118.37
-4.09%
|
123.42
+83.67%
|
67.19
|
| EBIT |
|
-477.17
-1145.41%
|
-38.31
+74.15%
|
-148.20
-218.68%
|
-46.51
|
| Total Unusual Items |
|
-446.33
-1589.50%
|
-26.42
+62.88%
|
-71.17
-633.88%
|
13.33
|
| Total Unusual Items Excluding Goodwill |
|
-446.33
-1589.50%
|
-26.42
+62.88%
|
-71.17
-633.88%
|
13.33
|
| Special Income Charges |
|
-393.79
-1390.60%
|
-26.42
+62.88%
|
-71.17
-633.88%
|
13.33
|
| Other Special Charges |
|
4.16
-78.02%
|
18.92
-9.94%
|
21.01
+106.14%
|
10.19
|
| Impairment Of Capital Assets |
|
398.00
+15278.67%
|
2.59
-89.25%
|
24.07
|
0.00
|
| Restructuring And Mergern Acquisition |
|
6.50
+32.33%
|
4.91
-72.71%
|
17.98
+176.46%
|
-23.52
|
| Write Off |
|
—
|
—
|
—
|
0.00
|
| Net Income |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-489.86%
|
-19.16
|
| Pretax Income |
|
-534.64
-748.14%
|
-63.04
+68.86%
|
-202.41
-226.05%
|
-62.08
|
| Net Non Operating Interest Income Expense |
|
-53.28
-177.82%
|
-19.18
+60.82%
|
-48.95
-244.64%
|
-14.20
|
| Interest Expense Non Operating |
|
57.47
+132.47%
|
24.72
-54.39%
|
54.20
+248.09%
|
15.57
|
| Net Interest Income |
|
-53.28
-177.82%
|
-19.18
+60.82%
|
-48.95
-244.64%
|
-14.20
|
| Interest Expense |
|
57.47
+132.47%
|
24.72
-54.39%
|
54.20
+248.09%
|
15.57
|
| Interest Income Non Operating |
|
4.19
-24.42%
|
5.54
+5.48%
|
5.26
+283.93%
|
1.37
|
| Interest Income |
|
4.19
-24.42%
|
5.54
+5.48%
|
5.26
+283.93%
|
1.37
|
| Other Income Expense |
|
-461.52
-1449.20%
|
-29.79
+77.50%
|
-132.40
-372.96%
|
-27.99
|
| Other Non Operating Income Expenses |
|
-15.55
-22975.00%
|
0.07
+100.11%
|
-62.52
-36.24%
|
-45.89
|
| Gain On Sale Of Security |
|
-52.54
|
—
|
—
|
—
|
| Tax Provision |
|
-0.13
+91.08%
|
-1.41
+98.42%
|
-89.36
-106.02%
|
-43.38
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
-89.52%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+100.00%
|
-0.58
+96.11%
|
-14.94
-633.88%
|
2.80
|
| Net Income Including Noncontrolling Interests |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-489.86%
|
-19.16
|
| Net Income From Continuing Operation Net Minority Interest |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-504.46%
|
-18.70
|
| Net Income From Continuing And Discontinued Operation |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-489.86%
|
-19.16
|
| Net Income Continuous Operations |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-504.46%
|
-18.70
|
| Net Income Discontinuous Operations |
|
—
|
0.00
|
0.00
+100.00%
|
-0.46
|
| Minority Interests |
|
—
|
—
|
—
|
—
|
| Normalized Income |
|
-88.18
-146.41%
|
-35.79
+37.02%
|
-56.82
-94.37%
|
-29.23
|
| Net Income Common Stockholders |
|
-579.40
-519.99%
|
-93.45
+34.31%
|
-142.26
-642.33%
|
-19.16
|
| Diluted EPS |
|
-5.07
-525.93%
|
-0.81
+36.72%
|
-1.28
-540.00%
|
-0.20
|
| Basic EPS |
|
-5.07
-525.93%
|
-0.81
+36.72%
|
-1.28
-540.00%
|
-0.20
|
| Basic Average Shares |
|
114.21
-0.41%
|
114.68
+3.08%
|
111.25
+18.73%
|
93.70
|
| Diluted Average Shares |
|
114.21
-0.41%
|
114.68
+3.08%
|
111.25
+18.73%
|
93.70
|
| Diluted NI Availto Com Stockholders |
|
-579.40
-519.99%
|
-93.45
+34.31%
|
-142.26
-642.33%
|
-19.16
|
| Depreciation Amortization Depletion Income Statement |
|
115.85
-2.13%
|
118.37
-4.09%
|
123.42
+83.67%
|
67.19
|
| Depreciation And Amortization In Income Statement |
|
115.85
-2.13%
|
118.37
-4.09%
|
123.42
+83.67%
|
67.19
|
| Earnings From Equity Interest |
|
0.36
+110.61%
|
-3.44
-366.74%
|
1.29
-71.77%
|
4.57
|
| Gain On Sale Of PPE |
|
14.87
|
0.00
+100.00%
|
-8.11
|
0.00
|
| Preferred Stock Dividends |
|
44.89
+41.03%
|
31.83
+8.94%
|
29.22
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,899.24
-25.36%
|
2,544.41
-5.07%
|
2,680.31
+47.49%
|
1,817.29
|
| Current Assets |
|
506.37
-16.59%
|
607.12
-11.20%
|
683.67
+43.01%
|
478.05
|
| Cash Cash Equivalents And Short Term Investments |
|
151.86
+45.73%
|
104.20
-45.96%
|
192.82
+2.46%
|
188.20
|
| Cash And Cash Equivalents |
|
151.86
+45.73%
|
104.20
-45.96%
|
192.82
+2.46%
|
188.20
|
| Receivables |
|
309.86
-25.28%
|
414.68
-7.18%
|
446.75
+75.41%
|
254.68
|
| Accounts Receivable |
|
309.86
-25.28%
|
414.68
-7.18%
|
446.75
+75.41%
|
254.68
|
| Gross Accounts Receivable |
|
330.58
-23.13%
|
430.05
-7.14%
|
463.11
+74.85%
|
264.86
|
| Allowance For Doubtful Accounts Receivable |
|
-20.72
-34.83%
|
-15.37
+6.07%
|
-16.36
-60.72%
|
-10.18
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Restricted Cash |
|
26.13
-55.93%
|
59.30
+330.67%
|
13.77
-5.00%
|
14.49
|
| Assets Held For Sale Current |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
18.52
-36.00%
|
28.94
-4.59%
|
30.33
+46.68%
|
20.68
|
| Total Non Current Assets |
|
1,392.86
-28.10%
|
1,937.29
-2.97%
|
1,996.63
+49.09%
|
1,339.24
|
| Net PPE |
|
85.16
+7.41%
|
79.28
-12.08%
|
90.18
-34.13%
|
136.90
|
| Gross PPE |
|
290.93
+12.26%
|
259.16
+4.19%
|
248.75
-13.44%
|
287.38
|
| Accumulated Depreciation |
|
-205.77
-14.40%
|
-179.88
-13.44%
|
-158.57
-5.38%
|
-150.48
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
16.99
+8.10%
|
15.72
-31.06%
|
22.80
-33.55%
|
34.31
|
| Construction In Progress |
|
268.13
+13.69%
|
235.83
+10.76%
|
212.91
+12.58%
|
189.12
|
| Other Properties |
|
4.37
-28.71%
|
6.13
-48.81%
|
11.98
-75.56%
|
49.03
|
| Leases |
|
1.44
-2.57%
|
1.48
+40.59%
|
1.05
-92.95%
|
14.93
|
| Goodwill And Other Intangible Assets |
|
1,279.42
-29.60%
|
1,817.48
-2.73%
|
1,868.55
+60.31%
|
1,165.56
|
| Goodwill |
|
694.48
-38.94%
|
1,137.32
+1.86%
|
1,116.54
+54.48%
|
722.77
|
| Other Intangible Assets |
|
584.94
-14.00%
|
680.16
-9.55%
|
752.01
+69.84%
|
442.78
|
| Investments And Advances |
|
8.97
+4.40%
|
8.59
+75.44%
|
4.89
+9.39%
|
4.47
|
| Long Term Equity Investment |
|
8.97
+4.40%
|
8.59
+75.44%
|
4.89
+9.39%
|
4.47
|
| Non Current Deferred Assets |
|
13.54
+1.19%
|
13.38
+10.38%
|
12.12
-30.59%
|
17.46
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
5.78
-68.85%
|
18.57
-11.13%
|
20.89
+40.74%
|
14.84
|
| Total Liabilities Net Minority Interest |
|
1,484.04
-3.83%
|
1,543.15
-4.31%
|
1,612.61
+68.35%
|
957.88
|
| Current Liabilities |
|
385.26
-46.16%
|
715.50
+6.12%
|
674.24
+55.56%
|
433.44
|
| Payables And Accrued Expenses |
|
125.53
-22.70%
|
162.39
-18.03%
|
198.09
+17.65%
|
168.37
|
| Payables |
|
59.78
-37.75%
|
96.03
+99.03%
|
48.25
-15.62%
|
57.17
|
| Accounts Payable |
|
59.78
-37.75%
|
96.03
+99.03%
|
48.25
-15.62%
|
57.17
|
| Current Accrued Expenses |
|
65.75
-0.91%
|
66.36
-55.71%
|
149.85
+34.76%
|
111.20
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
50.99
+51.21%
|
33.72
-40.20%
|
56.38
+7.48%
|
52.46
|
| Current Debt And Capital Lease Obligation |
|
15.34
-92.26%
|
198.18
+1935.16%
|
9.74
+36.73%
|
7.12
|
| Current Debt |
|
—
|
171.47
|
—
|
—
|
| Other Current Borrowings |
|
—
|
171.47
|
—
|
—
|
| Current Capital Lease Obligation |
|
15.34
-42.57%
|
26.72
+174.36%
|
9.74
+36.73%
|
7.12
|
| Current Deferred Liabilities |
|
1.20
-52.01%
|
2.51
-58.05%
|
5.98
+3.79%
|
5.76
|
| Current Deferred Revenue |
|
1.20
-52.01%
|
2.51
-58.05%
|
5.98
+3.79%
|
5.76
|
| Total Non Current Liabilities Net Minority Interest |
|
1,098.78
+32.76%
|
827.65
-11.80%
|
938.37
+78.93%
|
524.43
|
| Liabilities Heldfor Sale Non Current |
|
—
|
—
|
—
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
974.36
+89.02%
|
515.49
-18.83%
|
635.06
+35.41%
|
469.00
|
| Long Term Debt |
|
970.54
+97.86%
|
490.52
-17.84%
|
597.05
+44.57%
|
412.99
|
| Long Term Capital Lease Obligation |
|
3.82
-84.71%
|
24.97
-34.31%
|
38.01
-32.14%
|
56.01
|
| Tradeand Other Payables Non Current |
|
—
|
—
|
—
|
45.95
|
| Non Current Deferred Liabilities |
|
116.42
-2.18%
|
119.00
-1.85%
|
121.24
+139.17%
|
50.69
|
| Non Current Deferred Taxes Liabilities |
|
116.42
-2.18%
|
119.00
-1.85%
|
121.24
+139.17%
|
50.69
|
| Other Non Current Liabilities |
|
8.01
+168.50%
|
2.98
-17.95%
|
3.64
-23.33%
|
4.74
|
| Preferred Securities Outside Stock Equity |
|
—
|
190.17
+6.58%
|
178.43
|
0.00
|
| Stockholders Equity |
|
415.19
-58.53%
|
1,001.26
-6.22%
|
1,067.70
+24.24%
|
859.42
|
| Common Stock Equity |
|
415.19
-58.53%
|
1,001.26
-6.22%
|
1,067.70
+24.24%
|
859.42
|
| Capital Stock |
|
1.18
+0.86%
|
1.17
+1.04%
|
1.15
+13.69%
|
1.01
|
| Common Stock |
|
1.18
+0.86%
|
1.17
+1.04%
|
1.15
+13.69%
|
1.01
|
| Preferred Stock |
|
0.00
|
—
|
—
|
—
|
| Share Issued |
|
117.60
+0.88%
|
116.58
+1.00%
|
115.42
+13.72%
|
101.50
|
| Ordinary Shares Number |
|
111.63
-2.96%
|
115.04
+1.01%
|
113.89
+13.93%
|
99.96
|
| Treasury Shares Number |
|
5.97
+288.38%
|
1.54
+0.00%
|
1.54
+0.00%
|
1.54
|
| Additional Paid In Capital |
|
1,793.40
-0.58%
|
1,803.79
-0.24%
|
1,808.12
+21.61%
|
1,486.86
|
| Retained Earnings |
|
-1,315.33
-68.46%
|
-780.82
-8.57%
|
-719.19
-18.65%
|
-606.15
|
| Gains Losses Not Affecting Retained Earnings |
|
-2.62
-49.69%
|
-1.75
-39.46%
|
-1.26
-6.71%
|
-1.18
|
| Treasury Stock |
|
61.43
+190.82%
|
21.12
+0.00%
|
21.12
+0.00%
|
21.12
|
| Other Equity Adjustments |
|
-2.62
-49.69%
|
-1.75
-39.46%
|
-1.26
-6.71%
|
-1.18
|
| Total Equity Gross Minority Interest |
|
415.19
-58.53%
|
1,001.26
-6.22%
|
1,067.70
+24.24%
|
859.42
|
| Total Capitalization |
|
1,385.73
-7.11%
|
1,491.78
-10.39%
|
1,664.75
+30.84%
|
1,272.40
|
| Working Capital |
|
121.11
+211.74%
|
-108.38
-1249.23%
|
9.43
-78.86%
|
44.61
|
| Invested Capital |
|
1,385.73
-16.69%
|
1,663.25
-0.09%
|
1,664.75
+30.84%
|
1,272.40
|
| Total Debt |
|
989.70
+38.68%
|
713.67
+10.68%
|
644.80
+35.43%
|
476.12
|
| Net Debt |
|
818.68
+46.77%
|
557.78
+37.99%
|
404.22
+79.83%
|
224.79
|
| Capital Lease Obligations |
|
19.16
-62.93%
|
51.69
+8.25%
|
47.75
-24.37%
|
63.13
|
| Net Tangible Assets |
|
-864.23
-5.88%
|
-816.22
-1.92%
|
-800.85
-161.60%
|
-306.14
|
| Tangible Book Value |
|
-864.23
-5.88%
|
-816.22
-1.92%
|
-800.85
-161.60%
|
-306.14
|
| Current Provisions |
|
192.20
-39.69%
|
318.70
-21.12%
|
404.05
+102.30%
|
199.73
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
38.84
+107.00%
|
18.77
-86.84%
|
142.58
+1334.16%
|
-11.55
|
| Cash Flow From Continuing Operating Activities |
|
38.84
+107.00%
|
18.77
-86.84%
|
142.58
+1334.16%
|
-11.55
|
| Net Income From Continuing Operations |
|
-534.51
-767.39%
|
-61.62
+45.49%
|
-113.04
-489.86%
|
-19.16
|
| Depreciation Amortization Depletion |
|
115.85
-2.13%
|
118.37
-4.09%
|
123.42
+83.67%
|
67.19
|
| Depreciation And Amortization |
|
115.85
-2.13%
|
118.37
-4.09%
|
123.42
+83.67%
|
67.19
|
| Other Non Cash Items |
|
38.53
+8.18%
|
35.62
-27.60%
|
49.19
+563.80%
|
7.41
|
| Stock Based Compensation |
|
39.74
-0.02%
|
39.75
-1.86%
|
40.50
+19.19%
|
33.98
|
| Asset Impairment Charge |
|
398.00
+15278.67%
|
2.59
-89.25%
|
24.07
|
0.00
|
| Deferred Tax |
|
-2.18
+22.66%
|
-2.82
+91.00%
|
-31.27
-9243.86%
|
0.34
|
| Deferred Income Tax |
|
-2.18
+22.66%
|
-2.82
+91.00%
|
-31.27
-9243.86%
|
0.34
|
| Operating Gains Losses |
|
40.80
+1085.56%
|
3.44
-87.63%
|
27.83
+394.88%
|
5.62
|
| Gain Loss On Investment Securities |
|
52.54
|
—
|
—
|
—
|
| Change In Working Capital |
|
-57.38
+50.77%
|
-116.56
-632.42%
|
21.89
+120.47%
|
-106.94
|
| Change In Receivables |
|
73.70
+129.88%
|
32.06
+119.47%
|
-164.69
-59.93%
|
-102.98
|
| Changes In Account Receivables |
|
73.70
+129.88%
|
32.06
+119.47%
|
-164.69
-59.93%
|
-102.98
|
| Change In Prepaid Assets |
|
4.99
+10.60%
|
4.51
+142.50%
|
-10.61
-734.37%
|
1.67
|
| Change In Payables And Accrued Expense |
|
26.86
+163.02%
|
-42.62
-386.50%
|
14.88
+198.02%
|
-15.18
|
| Change In Accrued Expense |
|
20.23
+143.15%
|
-46.87
-316.99%
|
21.60
+176.21%
|
-28.34
|
| Change In Payable |
|
6.64
+56.29%
|
4.25
+163.19%
|
-6.72
-151.07%
|
13.16
|
| Change In Account Payable |
|
6.64
+56.29%
|
4.25
+163.19%
|
-6.72
-151.07%
|
13.16
|
| Change In Other Working Capital |
|
-134.77
-42.06%
|
-94.87
-147.80%
|
198.45
+1294.12%
|
14.23
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
2.50
|
| Change In Other Current Liabilities |
|
-28.17
-80.18%
|
-15.64
+3.07%
|
-16.13
-243.97%
|
-4.69
|
| Investing Cash Flow |
|
-0.23
+99.63%
|
-62.93
+84.86%
|
-415.54
-60.37%
|
-259.12
|
| Cash Flow From Continuing Investing Activities |
|
-91.55
-45.47%
|
-62.93
+84.88%
|
-416.12
-66.48%
|
-249.95
|
| Cash From Discontinued Investing Activities |
|
91.31
|
0.00
-100.00%
|
0.58
+106.30%
|
-9.16
|
| Net PPE Purchase And Sale |
|
—
|
—
|
—
|
-38.36
|
| Purchase Of PPE |
|
—
|
—
|
—
|
-38.36
|
| Capital Expenditure |
|
-34.09
-36.94%
|
-24.89
+13.40%
|
-28.75
+25.07%
|
-38.36
|
| Net Investment Purchase And Sale |
|
—
|
—
|
0.00
|
0.00
|
| Purchase Of Investment |
|
—
|
—
|
0.00
|
0.00
|
| Sale Of Investment |
|
—
|
—
|
0.00
|
0.00
|
| Net Business Purchase And Sale |
|
-0.01
+99.81%
|
-7.31
-940.69%
|
0.87
-84.33%
|
5.55
|
| Purchase Of Business |
|
-1.00
+86.34%
|
-7.32
|
0.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-34.09
-36.94%
|
-24.89
+13.40%
|
-28.75
+25.07%
|
-38.36
|
| Purchase Of Intangibles |
|
-34.09
-36.94%
|
-24.89
+13.40%
|
-28.75
+25.07%
|
-38.36
|
| Net Other Investing Changes |
|
-57.44
-86.96%
|
-30.73
+92.09%
|
-388.25
-78.80%
|
-217.14
|
| Financing Cash Flow |
|
-35.92
-6258.23%
|
-0.56
-100.20%
|
281.34
+113.88%
|
131.54
|
| Cash Flow From Continuing Financing Activities |
|
-35.92
-6258.23%
|
-0.56
-100.20%
|
281.34
+113.88%
|
131.54
|
| Net Issuance Payments Of Debt |
|
65.06
+11.07%
|
58.58
-68.04%
|
183.29
-16.59%
|
219.74
|
| Issuance Of Debt |
|
408.05
+596.61%
|
58.58
-90.95%
|
647.49
+194.66%
|
219.74
|
| Repayment Of Debt |
|
-342.98
|
0.00
+100.00%
|
-464.20
|
0.00
|
| Long Term Debt Issuance |
|
408.05
+596.61%
|
58.58
-90.95%
|
647.49
+194.66%
|
219.74
|
| Long Term Debt Payments |
|
-342.98
|
0.00
+100.00%
|
-464.20
|
0.00
|
| Net Long Term Debt Issuance |
|
65.06
+11.07%
|
58.58
-68.04%
|
183.29
-16.59%
|
219.74
|
| Short Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
-1.51
|
0.00
|
| Net Common Stock Issuance |
|
-40.00
|
0.00
|
0.00
|
—
|
| Common Stock Payments |
|
-40.00
|
0.00
|
0.00
|
—
|
| Common Stock Dividend Paid |
|
—
|
0.00
|
0.00
+100.00%
|
-14.88
|
| Cash Dividends Paid |
|
-11.13
+44.60%
|
-20.09
-6.87%
|
-18.79
-26.26%
|
-14.88
|
| Repurchase Of Capital Stock |
|
-40.00
|
0.00
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
3.46
-72.35%
|
12.52
+181.20%
|
4.45
|
| Net Other Financing Charges |
|
-49.86
-17.28%
|
-42.52
+33.23%
|
-63.68
+18.12%
|
-77.77
|
| Changes In Cash |
|
2.69
+106.00%
|
-44.73
-633.92%
|
8.38
+106.02%
|
-139.13
|
| Effect Of Exchange Rate Changes |
|
-0.49
-112.23%
|
-0.23
-189.87%
|
-0.08
+87.98%
|
-0.66
|
| Beginning Cash Position |
|
178.50
-20.12%
|
223.46
+3.86%
|
215.16
-39.38%
|
354.94
|
| End Cash Position |
|
180.70
+1.23%
|
178.50
-20.12%
|
223.46
+3.86%
|
215.16
|
| Free Cash Flow |
|
4.75
+177.59%
|
-6.13
-105.38%
|
113.84
+328.07%
|
-49.91
|
| Interest Paid Supplemental Data |
|
41.16
+103.66%
|
20.21
-62.29%
|
53.59
+754.86%
|
6.27
|
| Income Tax Paid Supplemental Data |
|
—
|
1.39
-71.67%
|
4.89
+250.18%
|
1.40
|
| Earnings Losses From Equity Investments |
|
-0.36
-110.61%
|
3.44
+366.74%
|
-1.29
+71.77%
|
-4.57
|
| Issuance Of Capital Stock |
|
0.00
|
0.00
-100.00%
|
168.00
|
0.00
|
| Net Preferred Stock Issuance |
|
0.00
|
0.00
-100.00%
|
168.00
|
0.00
|
| Preferred Stock Dividend Paid |
|
-11.13
+44.60%
|
-20.09
-6.87%
|
-18.79
|
0.00
|
| Preferred Stock Issuance |
|
0.00
|
0.00
-100.00%
|
168.00
|
0.00
|
| Sale Of Business |
|
0.99
+13985.71%
|
0.01
-99.20%
|
0.87
-84.33%
|
5.55
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 42026-03-04 View
- 10-K2026-02-25 View
- 8-K2026-02-24 View
- 42026-01-06 View
- 42026-01-05 View
- 8-K2025-12-08 View
- 8-K2025-12-02 View
- 42025-11-19 View
- 10-Q2025-11-07 View
- 8-K2025-11-06 View
- 8-K2025-09-23 View
- 8-K2025-08-21 View
- 8-K2025-08-19 View
- 8-K2025-08-18 View
- 10-Q2025-08-11 View
- 8-K2025-08-07 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|